AI Article Synopsis

  • Hepatic ischemia-reperfusion injury (IRI) occurs during liver surgery, especially affecting steatotic (fatty) livers that are more vulnerable to damage.
  • This study investigates how ferroptosis, a form of cell death, plays a role in IRI and assesses the impact of heme oxygenase-1-modified bone marrow mesenchymal stem cells (HO-1/BMMSCs) on this injury.
  • Results show that HO-1/BMMSCs can mitigate liver and cell damage by reducing ferroptosis and highlighting the essential role of the microRNA miR-29a-3p in this protective effect.

Article Abstract

Hepatic ischemia-reperfusion injury (IRI) is an inevitable result of liver surgery. Steatotic livers are extremely sensitive to IRI and have worse tolerance. Ferroptosis is considered to be one of the main factors of organ IRI. This study is aimed at exploring the role of ferroptosis in the effect of heme oxygenase-1-modified bone marrow mesenchymal stem cells (HO-1/BMMSCs) on steatotic liver IRI and its mechanism. An IRI model of a steatotic liver and a hypoxia reoxygenation (HR) model of steatotic hepatocytes (SHPs) were established. Rat BMMSCs were extracted and transfected with the gene to establish HO-1/BMMSCs, and their exosomes were extracted by ultracentrifugation. was knocked down to verify its role in ferroptosis and cell injury in SHP-HR. Public database screening combined with quantitative real-time reverse transcription PCR identified microRNAs (miRNAs) targeting in HO-1/BMMSCs exosomes. miR-29a-3p mimic and inhibitor were used for functional verification experiments. Liver function, histopathology, terminal deoxynulceotidyl transferase nick-end-labeling staining, cell viability, mitochondrial membrane potential, and cell death were measured to evaluate liver tissue and hepatocyte injury. Ferroptosis was assessed by detecting the levels of IREB2, Fe, malondialdehyde, glutathione, lipid reactive oxygen species, glutathione peroxidase 4, prostaglandin-endoperoxide synthase 2 mRNA, and mitochondrial morphology. The results revealed that HO-1/BMMSCs improved liver tissue and hepatocyte injury and suppressed ferroptosis and . The expression of IREB2 was increased in steatotic liver IRI and SHP-HR. Knocking down reduced the level of Fe and inhibited ferroptosis. HO-1/BMMSC exosomes reduced the expression of IREB2 and inhibited ferroptosis and cell damage. Furthermore, we confirmed high levels of miR-29a-3p in HO-1/BMMSCs exosomes. Overexpression of miR-29a-3p downregulated the expression of and inhibited ferroptosis. Downregulation of miR-29a-3p blocked the protective effect of HO-1/BMMSC exosomes on SHP-HR cell injury. In conclusion, ferroptosis plays an important role in HO-1/BMMSC-mediated alleviation of steatotic liver IRI. HO-1/BMMSCs could suppress ferroptosis by targeting via the exosomal transfer of miR-29a-3p.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203237PMC
http://dx.doi.org/10.1155/2022/6520789DOI Listing

Publication Analysis

Top Keywords

steatotic liver
20
liver iri
12
ho-1/bmmscs exosomes
12
inhibited ferroptosis
12
ferroptosis
11
liver
9
bone marrow
8
marrow mesenchymal
8
mesenchymal stem
8
stem cells
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!